Proton Pump Inhibitors Indian Medical PG Practice Questions and MCQs
Practice Indian Medical PG questions for Proton Pump Inhibitors. These multiple choice questions (MCQs) cover important concepts and help you prepare for your exams.
Proton Pump Inhibitors Indian Medical PG Question 1: All of the following adverse effects can be caused by loop diuretics except :
- A. Hypomagnesemia
- B. Hyperglycemia
- C. Hypercalcemia (Correct Answer)
- D. Hyperuricemia
Proton Pump Inhibitors Explanation: ***Hypercalcemia***
- Loop diuretics inhibit the reabsorption of calcium in the thick ascending limb of the loop of Henle, leading to **increased calcium excretion** and thus **hypocalcemia**, not hypercalcemia [2].
- This property makes them useful in treating conditions like hypercalcemia, but it means they do not cause hypercalcemia themselves.
*Hypomagnesemia*
- Loop diuretics inhibit magnesium reabsorption in the thick ascending limb, leading to **increased urinary magnesium excretion** and potential **hypomagnesemia** [1], [2].
- This electrolyte imbalance can contribute to cardiac arrhythmias and muscle weakness [2].
*Hyperglycemia*
- Loop diuretics, particularly in high doses, can decrease **insulin secretion** and increase **insulin resistance**, leading to **hyperglycemia**.
- This effect is generally mild but can be significant in patients with **diabetes mellitus**.
*Hyperuricemia*
- Loop diuretics compete with uric acid for secretion into the renal tubules, leading to **reduced uric acid excretion** and elevated serum uric acid levels, also known as **hyperuricemia** [1].
- This can precipitate or exacerbate **gout attacks** in susceptible individuals [1].
Proton Pump Inhibitors Indian Medical PG Question 2: Most effective medication in Gastroesophageal Reflux Disease (GERD) is:
- A. PPI (Correct Answer)
- B. Antacids
- C. Prokinetic drugs
- D. H2 blockers
Proton Pump Inhibitors Explanation: ***PPI***
- **Proton pump inhibitors (PPIs)** are considered the most effective medications for GERD because they **irreversibly block the H+/K+-ATPase pump** in gastric parietal cells, leading to substantial and prolonged reduction in acid secretion. [1]
- This profound acid suppression promotes **healing of esophageal erosions** and provides superior symptom relief compared to other drug classes. [1]
*Antacids*
- **Antacids** neutralize existing stomach acid, providing **rapid but temporary symptomatic relief**. [1]
- They do not inhibit acid production and are **ineffective for long-term management** or healing of esophageal damage in GERD.
*Prokinetic drugs*
- **Prokinetic agents** enhance esophageal motility and gastric emptying, which can be beneficial in some GERD patients by reducing acid exposure.
- However, they do **not reduce acid secretion** and are generally less effective than PPIs for primary GERD treatment.
*H2 blockers*
- **H2-receptor antagonists (H2 blockers)** reduce stomach acid production by blocking histamine H2 receptors on parietal cells, leading to a moderate decrease in acid secretion.
- While effective for mild GERD, they are generally **less potent and provide less sustained acid suppression** than PPIs [1], and patients can develop **tachyphylaxis** (tolerance) to their effects.
Proton Pump Inhibitors Indian Medical PG Question 3: Proton pump inhibitors for peptic ulcer disease should be taken:
- A. Before Breakfast (Correct Answer)
- B. After Breakfast
- C. Before Dinner
- D. After Dinner
Proton Pump Inhibitors Explanation: ***Before Breakfast***
- Proton pump inhibitors (PPIs) are most effective when taken **30-60 minutes before the first meal of the day**.
- This timing allows the drug to reach peak plasma concentration when the greatest number of **proton pumps** are activated by food intake, maximizing their inhibitory effect on acid secretion.
*After Breakfast*
- Taking PPIs after breakfast significantly reduces their effectiveness because many **proton pumps** would have already been active and subsequently inactivated before the drug can exert its full effect.
- This timing leads to suboptimal acid suppression, potentially hindering the healing of **peptic ulcers**.
*Before Dinner*
- While taking a second daily dose before dinner can be beneficial for some patients with persistent symptoms, it is not the primary or most effective administration time for a **once-daily dose**.
- The main goal is to suppress the **meal-stimulated acid secretion** throughout the day, which is best achieved by the morning dose.
*After Dinner*
- Administering PPIs after dinner is generally ineffective for the same reasons as taking them after breakfast; the **proton pumps** have already been activated and then inactivated, diminishing the drug's impact.
- This timing would lead to inadequate acid control, especially during the day when most acid secretion occurs.
Proton Pump Inhibitors Indian Medical PG Question 4: Which of the following drugs can cause hypertrophic pyloric stenosis?
- A. Nifedipine
- B. Vancomycin
- C. Phenyl propanolamine
- D. Erythromycin (Correct Answer)
Proton Pump Inhibitors Explanation: ***Erythromycin***
- **Erythromycin** use in infants, particularly during the first few weeks of life, has been associated with an increased risk of developing **hypertrophic pyloric stenosis**.
- The mechanism is believed to involve the drug's properties as a **motilin receptor agonist**, which may affect the development or function of the pyloric sphincter.
*Nifedipine*
- **Nifedipine** is a calcium channel blocker primarily used for cardiovascular conditions like hypertension and angina.
- It works by relaxing smooth muscles and is not linked to the development of **pyloric stenosis**.
*Vancomycin*
- **Vancomycin** is an antibiotic used for severe bacterial infections, particularly against Gram-positive bacteria.
- It is not associated with the development of **hypertrophic pyloric stenosis**.
*Phenylpropanolamine*
- **Phenylpropanolamine** is a sympathomimetic drug previously used as a decongestant and anorectic.
- It primarily affects alpha-adrenergic receptors and has no established link to **pyloric stenosis**.
Proton Pump Inhibitors Indian Medical PG Question 5: A 70 kg man was given a drug with a dose of 100 mg/kg body weight, twice daily. The half-life (t1/2) is 10 hours, the plasma concentration is 1.9 mg/mL, and the clearance is unknown. What is the clearance of this drug?
- A. 20 liter/hr
- B. K is 0.0693
- C. 0.22 L/hr (Correct Answer)
- D. 0.02 L/hr
Proton Pump Inhibitors Explanation: ***0.22 L/hr***
- To calculate clearance at steady state, we use the formula: **Clearance (Cl) = Dose Rate / Css** (steady-state plasma concentration).
- **Dose rate calculation**: 100 mg/kg × 70 kg × 2 doses/day = 14,000 mg/day = 583.33 mg/hr
- **Converting plasma concentration**: 1.9 mg/mL = 1900 mg/L
- **Clearance calculation**: Cl = 583.33 mg/hr ÷ 1900 mg/L = **0.307 L/hr**
- **Note**: The calculated value (0.307 L/hr) does not exactly match any option. The marked answer (0.22 L/hr) is the closest approximation among the given choices. This discrepancy may arise from rounding in the original question parameters or implicit assumptions about bioavailability/volume of distribution.
*0.02 L/hr*
- This value is approximately 15 times lower than the calculated clearance.
- Such low clearance would result in much higher plasma concentrations or require significantly lower dosing.
*20 liter/hr*
- This clearance is approximately 65 times higher than calculated, representing an unrealistically high value for this scenario.
- Such high clearance would result in very low plasma concentrations unless extremely high doses were administered.
*K is 0.0693*
- This represents the **elimination rate constant (k)**, calculated as k = 0.693/t1/2 = 0.693/10 hr = 0.0693 hr⁻¹.
- While mathematically correct for k, the question specifically asks for **clearance**, not the elimination rate constant.
- Clearance is related to k by: Cl = k × Vd (volume of distribution).
Proton Pump Inhibitors Indian Medical PG Question 6: Identify the correct match, regarding the drug and its adverse effect.
- A. Aliskiren - hypokalemia
- B. Hydralazine - heart failure
- C. Atenolol - hemolytic anemia
- D. Verapamil - constipation (Correct Answer)
Proton Pump Inhibitors Explanation: ***Verapamil - Constipation***
- **Verapamil**, a **non-dihydropyridine calcium channel blocker**, frequently causes constipation due to its effect on smooth muscle in the gastrointestinal tract, leading to **decreased intestinal motility**.
- This adverse effect is common and often dose-dependent, making it a significant consideration in patient management.
*Aliskiren - hypokalemia*
- **Aliskiren**, a **direct renin inhibitor**, can cause **hyperkalemia** by reducing angiotensin II levels, which normally stimulate aldosterone secretion.
- It does not typically cause hypokalemia; rather, potassium-sparing effects are often observed.
*Hydralazine - heart failure*
- **Hydralazine** is a **vasodilator** used to treat hypertension and **heart failure** with reduced ejection fraction by reducing afterload.
- It does not cause heart failure; instead, it is often prescribed to improve cardiac function in patients with heart failure.
*Atenolol - hemolytic anemia*
- **Atenolol** is a **beta-blocker** primarily used for hypertension, angina, and arrhythmias.
- **Hemolytic anemia** is a rare adverse effect associated with certain drugs, but it is not a known or common side effect of atenolol.
Proton Pump Inhibitors Indian Medical PG Question 7: Which of the following is the most common adverse effect of omeprazole?
- A. Headache (Correct Answer)
- B. Constipation
- C. Liver dysfunction
- D. Upper gastrointestinal bleeding
Proton Pump Inhibitors Explanation: ***Headache***
- **Headache** is the most frequently reported adverse effect of omeprazole and other proton pump inhibitors (PPIs), occurring in approximately 2-7% of patients.
- While generally mild and self-limiting, it is the most common reason for patients to report side effects during PPI therapy.
- Other common adverse effects include diarrhea, nausea, and abdominal pain, but headache remains the most prevalent.
*Constipation*
- Constipation can occur with omeprazole use, but it is less common than headache or diarrhea.
- Gastrointestinal side effects like constipation typically occur in a smaller proportion of patients compared to headache.
*Liver dysfunction*
- Mild **transient elevation of liver enzymes** can occur with omeprazole, but clinically significant liver dysfunction is rare.
- Routine monitoring of liver function is generally not required unless there is pre-existing hepatic impairment.
*Upper gastrointestinal bleeding*
- Omeprazole is used to **treat and prevent** upper gastrointestinal bleeding by reducing gastric acid secretion in conditions like peptic ulcers and erosive esophagitis.
- It is a therapeutic agent for this condition, not a causative factor.
Proton Pump Inhibitors Indian Medical PG Question 8: A 40-year-old male with gastroesophageal reflux disease (GERD) is found to have Barrett's esophagus with low-grade dysplasia on endoscopy. What is the most appropriate initial pharmacological treatment for this condition?
- A. Fundoplication
- B. Esophageal resection
- C. PPI (Correct Answer)
- D. Diet modification
Proton Pump Inhibitors Explanation: ***PPI***
- In patients with **GERD** and **low-grade dysplasia**, high-dose **proton pump inhibitors (PPIs)** are the initial treatment of choice to suppress acid reflux.
- Continuous acid suppression can help in the regression of dysplasia and prevent its progression to higher grades.
*Fundoplication*
- **Fundoplication** is a surgical procedure to treat severe GERD, but it is not the primary initial treatment for low-grade dysplasia.
- It might be considered if medical therapy with PPIs fails or if there are significant anatomical defects.
*Esophageal resection*
- **Esophageal resection** is a major surgical procedure typically reserved for **high-grade dysplasia** or **esophageal adenocarcinoma**.
- It is an overly aggressive and unnecessary intervention for initial management of low-grade dysplasia.
*Diet modification*
- **Diet modification** is an important adjunctive therapy for GERD symptoms and overall gastric health.
- However, it is generally insufficient as a standalone initial treatment for documented **low-grade dysplasia** without concurrent pharmacotherapy.
Proton Pump Inhibitors Indian Medical PG Question 9: Which antitubercular drug reduces the efficacy of oral contraceptive pills (OCPs)?
- A. Rifampicin (Correct Answer)
- B. Isoniazid
- C. Ethambutol
- D. Pyrazinamide
- E. Streptomycin
Proton Pump Inhibitors Explanation: ***Rifampicin***
- **Rifampicin** is a potent inducer of **cytochrome P450 enzymes**, particularly CYP3A4, which metabolize oral contraceptive pills (OCPs).
- This increased metabolism leads to lower systemic levels of contraceptive hormones, reducing their efficacy and increasing the risk of **unintended pregnancy**.
- Women on Rifampicin should use **additional barrier contraception** or alternative contraceptive methods.
*Isoniazid*
- **Isoniazid** is primarily metabolized by N-acetyltransferase and cytochrome P450, but it is not a significant enzyme inducer.
- It does not typically interfere with the effectiveness of **oral contraceptive pills**.
*Ethambutol*
- **Ethambutol** is eliminated largely unchanged via renal excretion and is not a significant inducer or inhibitor of cytochrome P450 enzymes.
- It does not interact with **oral contraceptive pills**.
*Pyrazinamide*
- **Pyrazinamide** is metabolized by the liver, but it does not significantly induce or inhibit the cytochrome P450 system involved in OCP metabolism.
- It is not known to reduce the effectiveness of **oral contraceptive pills**.
*Streptomycin*
- **Streptomycin** is an aminoglycoside antibiotic that is not metabolized by the liver and does not affect cytochrome P450 enzymes.
- It has no interaction with **oral contraceptive pills**.
Proton Pump Inhibitors Indian Medical PG Question 10: What is the treatment of choice in duodenal ulcer without any complications of hemorrhage?
- A. Highly selective vagotomy
- B. Trunkal vagotomy
- C. Proton pump inhibitors (Correct Answer)
- D. None of the options
Proton Pump Inhibitors Explanation: ***Proton pump inhibitors***
- **Proton pump inhibitors (PPIs)** are the first-line and most effective treatment for uncomplicated duodenal ulcers due to their potent and sustained acid suppression [1].
- They work by irreversibly inhibiting the **H+/K+-ATPase pump** in the stomach's parietal cells, reducing acid secretion and allowing the ulcer to heal [1].
*Highly selective vagotomy*
- This is a surgical procedure that was historically used to reduce acid secretion by denervating the acid-producing parietal cells of the stomach, but it is **not the primary treatment** for uncomplicated ulcers today due to the availability of effective medical therapy [1].
- It carries surgical risks and is generally reserved for **refractory cases** or those with complications not amenable to endoscopic or medical management [1].
*Trunkal vagotomy*
- **Trunkal vagotomy** involves cutting the main vagal trunks, which leads to significant side effects such as **gastric stasis** (delayed emptying) and diarrhea, often requiring a drainage procedure (e.g., pyloroplasty).
- It was used in the past but is **rarely performed** for uncomplicated duodenal ulcers due to its associated morbidity and the effectiveness of modern medical treatments [1].
*None of the options*
- This option is incorrect because **proton pump inhibitors** are indeed a highly effective and standard treatment for uncomplicated duodenal ulcers [1].
More Proton Pump Inhibitors Indian Medical PG questions available in the OnCourse app. Practice MCQs, flashcards, and get detailed explanations.
